Skip to main content

Table 1 Baseline characteristics of the study populations in the 10 studies included in the meta-analysis

From: Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis

Author year

Regimen

Age (years)

Sample size (females)

BMI (kg/m2)

HbA1c (%)

FBG (mmol/l)

Type of diabetes

Duration of DM

Dose of injected cells

Mode of injection

Follow-up (months)

Carlsso

n 2015 [23]

hBM-MSCs

Control

24±6

27±6

9(1)

9(4)

23.3±3.3

22.5± 2.7

None

None

TIDM

None

2.75×106/kg

IV

12

Yu 2011 [25]

hUC-MSCs

Control

19.67±2.58

14.83±8.18

6(3)

6(2)

21.56±1.67

20.08± 3.48

10.53± 0.98

9.16± 3.30

8.23±2.12

8.08±1.83

TIDM

≦3months

1×107

IV

9

Hu 2013 [26]

WJ-MSCs

Control

17.6±33.69

18.2±30.60

15(6)

14(6)

20.9±14.33

21.3±15.71

6.85±2.87

6.79±3.14

5.7±1.71

5.4±1.64

TIDM

≦6months

(2.6±1.2)×107

IV

24

Zhang 2016 [24]

AD-MSCs

Control

22. 1 ± 6. 6

21. 6 ± 6. 8

16(7)

17(7)

20.8 ±1.9

21.1±1.9

6.76±1.25

6.71±1.43

5.92 ±1.68

6.13 ±1.49

TIDM

3.5 ±2.9 (months)

3. 7 ± 5. 5 (months)

1×107/kg

IV

24

Bhansali 2017 [18]

ABM-MSCs

ABM-MSCs

Control

47.9±18.9

44.6±8.9

51.7±13.3

10(2)

10(3)

10(4)

28.8±4.4

27.9±4.5

26.4±3.8

6.8±0.3

6.8±0.8

6.5±0.5

5.8±0.8

6.0±0.8

6.1±1.0

T2DM

15.3±12.7(years)

10.2±1.3(years)

12.5±5.2(years)

(1.2±0.3)×109

SPD artery

Splenic artery

12

Guan 2015 [17]

hUC-MSCs

40.5 ± 9.21

6(0)

23.7±0.71

8.55±1.45

None

T2DM

42.7±31.89(months)

(0.88±0.05)×106

Elbow vein

33.2±2.82

Liu 2014 [19]

WJ-MSCs

52.9± 10.5

22(7)

25.1 ± 2.4

8.20 ±1.69

7.53 ± 2.67

T2DM

8.7 ± 4.3(years)

1×106/kg

Spleen artery

12

Kong 2014 [28]

hUC -MSCs

Control

52.75± 12.69

8(3)

10(3)

25.94± 4.11

26.75± 4.32

7.30±1.49

None

9.17± 1.92

8.42±1.25

T2DM

6.87± 4.73(years)

11.4± 8.38 (years)

1.8×106/kg

IV

6

Hu 2016 [29]

WJ-MSCs

Control

52.43±4.88

53.21±8.22

31(14)

30(14)

26.74±5.41

27.03±6.68

7.67±1.23

7.54±1.31

8.24±1.55

7.91±1.44

T2DM

8.93±5.67(years)

8.3±6.07 (years)

1×106/kg

IV

36

Jiang 2011 [30]

PD-MSCs

66

10(3)

None

9.8±2.2

None

T2DM

3–20(years)

1.35 ×106/kg

IV

≧3

  1. Abbreviations: BMI body mass index, HbA1c glycated hemoglobin, FBG fasting blood glucose, DM diabetes mellitus, T1DM type 1 diabetes, T2DM type 2 diabetes, SPD superior pancreaticoduodenal artery, hBM-MSCs human bone marrow mesenchymal stem cells, hUC-MSCs human umbilical cord mesenchymal stem cells, WJ-MSCs Wharton’s jelly mesenchymal stem cells, AD-MSCs adipose mesenchymal stem cells, PD-MSCs placenta-derived mesenchymal stem cells